IAG . Bankinter Fija su Precio Objetivo en 3,50€ Por Acción . En Marcha la Recompra de Acciones . : Peaches Biotech Publishes Positive “ In Vivo ” Results Of Its Drug PRS CK STORM Against The Cytokine Storm Associated With Infectious Processes, Including COVID19 .

30 mayo 2022

Peaches Biotech Publishes Positive “ In Vivo ” Results Of Its Drug PRS CK STORM Against The Cytokine Storm Associated With Infectious Processes, Including COVID19 .

Peaches Biotech Publishes Positive “ In Vivo ” Results of Its Drug PRS CK STORM .

*.- The Results Show The High efficacy and Safety of PRS CK STORM as a Medicine to Prevent and Treat The Cytokine Storm Associated With Infectious Processes of Any Kind, Including COVID-19 .

*.- Longside Peaches Biotech, the Biomedical Research Center of Aragón, The Bioincubator of The University Hospital of Fuenlabrada, as Well as The Histocell Advanced CELL Therapy Factory in Bilbao Have Participated in This Study .

*.- The Company Plans to Start Clínical Trials in Various Hospitals of Madrid in The coming Months . ...